The bowel disease treatment race is gaining momentum after Spyre Therapeutics reported positive results from a mid-stage clinical trial of its experimental ulcerative colitis drug, SPY002.
A Rs 500 crore AI healthcare hub is set to transform Telangana as Hyderabad-based Pulsus Group announced a major investment to expand its presence in the state's healthcare and technology ecosystem.
.jpeg "Copper-Based Drug Shows Promise in Alzheimer's Treatment")
A copper-based drug shows potential in reducing toxic proteins and improving cognition in Alzheimer’s, offering a new approach targeting brain waste clearance mechanisms.
India has gained access to a globally acclaimed prostate cancer therapy with the launch of Pluvicto by Novartis.The company announced the introduction of Pluvicto in India for eligible patients with advanced prostate cancer, marking...
HLL rolls out AMRIT Plus, a premium pharmacy chain as the government-owned healthcare company expands its presence in India's healthcare sector. HLL Lifecare has launched AMRIT Plus, a premium pharmacy chain designed to offer medicines, wellness...
Fresh investment discussions between India and Switzerland could influence the future of India's leading life sciences hubs. The latest talks between India and Switzerland signal growing interest among Swiss companies in India's expanding life...
.jpg "Maharashtra FDA Cracks Down on Hospital Pharmacy Monopoly")
The Maharashtra FDA has brought major relief to patients across the state with hospital pharmacy monopoly crackdown. In a fresh directive, the Maharashtra Food and Drug Administration (FDA) has instructed hospitals, doctors, and hospital-linked...
Sagility's AI growth strategy received a major boost after the healthcare services provider announced the acquisition of U.S.-based CareSeed, a company known for its healthcare quality analytics and HEDIS reporting solutions.
Alembic Pharma received a major regulatory boost after securing USFDA approval for its Tretinoin Cream USP, 0.025 percent. The development lifted investor sentiment, with Alembic Pharma shares gaining in trade following the announcement.
Jharkhand is building a multi-stakeholder model to end TB as the state government sets an ambitious target to eliminate tuberculosis by 2029. The announcement was made by Health Minister Irfan Ansari during a National Task Force meeting under...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")